中文名稱：兔抗STAT1 (Phospho-Tyr701)多克隆抗體

英文名稱： Anti-STAT1 (Phospho-Tyr701) rabbit polyclonal antibody

別名： CANDF7; ISGF-3; STAT91

相關(guān)類別：一抗

儲(chǔ) 存： 冷凍（-20℃）避光

宿主： Rabbit

抗原： STAT1 (Phospho-Tyr701)

反應(yīng)種屬： Human Mouse

標(biāo) 記物： Unconjugate

克隆類型： rabbit polyclonal

技術(shù)規(guī)格

Background:

Signal transducer and activator of transcription that mediates signaling by interferons (IFNs). Following type I IFN (IFN-alpha and IFN-beta) binding to cell surface receptors, Jak kinases (TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. The phosphorylated STATs dimerize, associate with ISGF3G/IRF-9 to form a complex termed ISGF3 transcription factor, that enters the nucleus. ISGF3 binds to the IFN stimulated response element (ISRE) to activate the transcription of interferon stimulated genes, which drive the cell in an antiviral state. In response to type II IFN (IFN-gamma), STAT1 is tyrosine- and serine-phosphorylated. It then forms a homodimer termed IFN-gamma-activated factor (GAF), migrates into the nucleus and binds to the IFN gamma activated sequence (GAS) to drive the expression of the target genes, inducing a cellular antiviral state.

Applications:

WB, IHC

Name of antibody:

STAT1 (Phospho-Tyr701)

Immunogen:

Synthetic peptide of human STAT1 (Phospho-Tyr701)

Full name:

signal transducer and activator of transcription 1, 91kDa (Phospho-Tyr701)

Synonyms：

CANDF7; ISGF-3; STAT91

SwissProt:

P42224

IHC positive control:

Human breast carcinoma

IHC Recommend dilution:

50-100

WB Predicted band size:

87 kDa

WB Positive control:

Hela cells treated with IFN

WB Recommended dilution:

500-1000

展開(kāi)全部

兔抗STAT1 (Phospho-Tyr701)多克隆抗體說(shuō)明書(shū)
下載

久久综合九九-久久综合九九亚洲一区-久久综合九色-久久综合九色欧美综合狠狠-久久综合九色婷婷97-久久综合九色综合8888

021-54845833/15800441009

ELISA試劑盒

PCR試劑盒

生化試劑盒

細(xì)胞系

細(xì)胞庫(kù)

基礎(chǔ)培養(yǎng)基

完全培養(yǎng)基

原代細(xì)胞

細(xì)胞專用培養(yǎng)基

菌株

生化試劑

病理染色液

科研抗體

標(biāo)準(zhǔn)品

血清

形態(tài)病理檢測(cè)

分子病理

超微病理

產(chǎn)品中心

最新產(chǎn)品

相關(guān)文章

兔抗STAT1 (Phospho-Tyr701)多克隆抗體

Background:	Signal transducer and activator of transcription that mediates signaling by interferons (IFNs). Following type I IFN (IFN-alpha and IFN-beta) binding to cell surface receptors, Jak kinases (TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. The phosphorylated STATs dimerize, associate with ISGF3G/IRF-9 to form a complex termed ISGF3 transcription factor, that enters the nucleus. ISGF3 binds to the IFN stimulated response element (ISRE) to activate the transcription of interferon stimulated genes, which drive the cell in an antiviral state. In response to type II IFN (IFN-gamma), STAT1 is tyrosine- and serine-phosphorylated. It then forms a homodimer termed IFN-gamma-activated factor (GAF), migrates into the nucleus and binds to the IFN gamma activated sequence (GAS) to drive the expression of the target genes, inducing a cellular antiviral state.
Applications:	WB, IHC
Name of antibody:	STAT1 (Phospho-Tyr701)
Immunogen:	Synthetic peptide of human STAT1 (Phospho-Tyr701)
Full name:	signal transducer and activator of transcription 1, 91kDa (Phospho-Tyr701)
Synonyms：	CANDF7; ISGF-3; STAT91
SwissProt:	P42224
IHC positive control:	Human breast carcinoma
IHC Recommend dilution:	50-100
WB Predicted band size:	87 kDa
WB Positive control:	Hela cells treated with IFN
WB Recommended dilution:	500-1000